Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,219,369
+$419,985 QoQ
Shares Held
508,071
-0.8% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 149 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. LXRX ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in LXRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,219,369 | 508,071 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $799,384 | 512,426 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $684,115 | 594,883 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $703,894 | 521,403 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $399,665 | 420,700 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $131,448 | 285,759 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $77,323 | 104,494 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $102,164 | 65,074 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $100,368 | 59,743 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $119,562 | 49,818 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $93,607 | 61,182 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $56,611 | 51,937 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $91,866 | 40,117 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $99,561 | 40,972 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $78,735 | 41,223 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $75,246 | 31,353 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $53,051 | 28,523 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $62,383 | 29,849 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $113,384 | 28,778 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $133,490 | 27,753 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $106,418 | 23,185 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $73,204 | 12,471 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $112,257 | 32,824 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,876 | 23,526 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $46,870 | 23,435 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||